US Stock MarketDetailed Quotes

IART Integra Lifesciences

Watchlist
  • 21.538
  • -0.023-0.10%
Trading Aug 19 11:21 ET
1.67BMarket Cap74.27P/E (TTM)

Integra Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
42.87%40.4M
-39.76%15.76M
-47.08%139.96M
-31.15%58.75M
-60.81%26.77M
-57.46%28.28M
-41.02%26.16M
-15.35%264.47M
23.18%85.33M
-17.48%68.31M
Net income from continuing operations
-396.41%-12.4M
-113.54%-3.28M
-62.48%67.74M
-62.54%19.83M
-60.94%19.5M
-90.66%4.18M
-26.37%24.23M
6.79%180.55M
16.66%52.95M
15.47%49.92M
Operating gains losses
1,646.91%1.25M
152.17%12K
110.42%777K
110.11%781K
121.65%100K
-505.00%-81K
-103.23%-23K
81.15%-7.46M
-2,133.42%-7.73M
-121.26%-462K
Depreciation and amortization
19.31%36.78M
-1.85%30.57M
4.41%123.51M
5.05%30.99M
3.70%30.56M
4.10%30.83M
4.77%31.14M
-1.28%118.3M
-4.07%29.5M
-2.17%29.47M
Deferred tax
-712.33%-1.84M
-246.24%-2.86M
-159.21%-11.89M
-146.48%-14.85M
120.27%1.24M
-105.68%-227K
-44.89%1.95M
-66.42%-4.59M
-156.07%-6.02M
28.96%-6.1M
Other non cash items
1.76%3.36M
-74.48%2M
299.58%21.24M
831.71%6.11M
138.73%3.98M
268.56%3.3M
733.23%7.85M
-222.31%-10.64M
-21.81%656K
-578.15%-10.29M
Change In working capital
106.26%938K
45.20%-23.35M
-106.94%-81.57M
-1.59%10.09M
-969.18%-34.06M
10.34%-14.99M
-43.14%-42.61M
-317.03%-39.42M
140.62%10.26M
-153.55%-3.19M
-Change in receivables
-28.78%-6.72M
67.58%16.83M
113.55%4.59M
95.45%-457K
101.57%224K
19.97%-5.22M
422.24%10.04M
-566.69%-33.91M
1.35%-10.04M
-314.59%-14.24M
-Change in inventory
181.75%1.74M
25.18%-19.02M
-105.24%-59.77M
-250.84%-16.42M
-130.01%-15.8M
64.56%-2.13M
-119.90%-25.42M
-641.94%-29.12M
-152.17%-4.68M
-5.79%-6.87M
-Change in prepaid assets
-68.87%-14.1M
-23.66%-2.68M
-69.21%2.65M
248.73%24.35M
-294.61%-11.19M
-1,001.51%-8.35M
57.11%-2.16M
140.73%8.61M
173.92%6.98M
258.16%5.75M
-Change in payables and accrued expense
238.07%15.07M
-285.43%-19.21M
-216.64%-20.23M
-89.46%1.91M
-145.39%-6.24M
-127.30%-10.92M
48.90%-4.98M
-47.24%17.34M
1,944.11%18.15M
108.98%13.75M
-Change in other current assets
522.16%9.18M
105.64%339K
-291.15%-8.54M
102.03%239K
-120.80%-590K
-148.82%-2.18M
-363.21%-6.01M
-127.71%-2.18M
-695.29%-11.76M
54.77%2.84M
-Change in other current liabilities
-158.60%-7.91M
113.02%1.89M
90.76%-410K
-95.10%483K
101.78%110K
343.59%13.5M
-463.00%-14.5M
68.55%-4.44M
163.06%9.85M
-700.78%-6.17M
-Change in other working capital
1,147.28%3.67M
-448.37%-1.5M
-97.01%128K
-100.74%-13K
-133.31%-583K
--294K
--430K
15,164.29%4.27M
--1.75M
--1.75M
Cash from discontinued investing activities
Operating cash flow
42.87%40.4M
-39.76%15.76M
-47.08%139.96M
-31.15%58.75M
-60.81%26.77M
-57.46%28.28M
-41.02%26.16M
-15.35%264.47M
23.18%85.33M
-17.48%68.31M
Investing cash flow
Cash flow from continuing investing activities
-1,972.28%-322.2M
-293.79%-53.97M
-60.77%-94.18M
-4.39%-57.23M
-151.99%-7.7M
-245.66%-15.55M
2.58%-13.7M
63.71%-58.58M
-99.45%-54.82M
274.69%14.81M
Net PPE purchase and sale
-91.07%-29.71M
-12.85%-15.47M
-114.32%-66.87M
-641.01%-24.54M
-42.85%-13.08M
-65.28%-15.55M
-46.96%-13.7M
35.03%-31.2M
87.93%-3.31M
-25.70%-9.16M
Net intangibles purchase and sale
----
----
--0
--0
----
----
----
-8,075.86%-4.74M
--0
--0
Net business purchase and sale
----
----
--0
--0
--0
----
----
75.72%-27.55M
---51.51M
----
Net investment purchase and sale
---10.5M
---38.5M
-656.39%-27.31M
---32.69M
--5.38M
--0
--0
6,359.21%4.91M
--0
--0
Cash from discontinued investing activities
Investing cash flow
-1,972.28%-322.2M
-293.79%-53.97M
-60.77%-94.18M
-4.39%-57.23M
-151.99%-7.7M
-245.66%-15.55M
2.58%-13.7M
63.71%-58.58M
-99.45%-54.82M
274.69%14.81M
Financing cash flow
Cash flow from continuing financing activities
-776.72%-93.75M
320.48%358.68M
8.74%-229.93M
92.95%-6.89M
-549.82%-49.66M
18.67%-10.69M
-21.89%-162.68M
-156.50%-251.95M
-18,852.21%-97.7M
-538.44%-7.64M
Net issuance payments of debt
-171.32%-31.74M
16,254.55%355.4M
150.56%54.5M
93.58%-6.5M
1,252.31%74.9M
-2,440.00%-11.7M
-340.00%-2.2M
-7.80%-107.8M
-12,762.50%-101.3M
-712.50%-6.5M
Net common stock issuance
---50M
--0
-120.00%-275M
--0
---125M
--0
-20.00%-150M
---125M
--0
--0
Proceeds from stock option exercised by employees
--0
175.06%6.4M
-21.01%4.32M
-94.19%225K
--655K
214.73%1.11M
87.73%2.33M
-19.92%5.47M
1,541.10%3.87M
--0
Net other financing activities
-11,442.31%-12M
75.63%-3.12M
44.18%-13.74M
-126.10%-615K
81.26%-214K
99.26%-104K
-39.17%-12.81M
-387.49%-24.62M
47.18%-272K
-158.37%-1.14M
Cash from discontinued financing activities
Financing cash flow
-776.72%-93.75M
320.48%358.68M
8.74%-229.93M
92.95%-6.89M
-549.82%-49.66M
18.67%-10.69M
-21.89%-162.68M
-156.50%-251.95M
-18,852.21%-97.7M
-538.44%-7.64M
Net cash flow
Beginning cash position
92.57%591.91M
-39.47%276.4M
-11.06%456.66M
-46.53%273.73M
-30.85%309.19M
-24.50%307.37M
-11.06%456.66M
9.21%513.45M
8.87%511.94M
12.52%447.15M
Current changes in cash
-18,527.13%-375.55M
313.32%320.47M
-299.77%-184.15M
92.01%-5.37M
-140.52%-30.59M
-95.83%2.04M
-45.59%-150.23M
-187.31%-46.06M
-258.78%-67.19M
-0.75%75.48M
Effect of exchange rate changes
-428.17%-1.13M
-629.67%-4.96M
136.27%3.89M
-32.50%8.04M
54.41%-4.87M
97.57%-213K
129.58%937K
-13.16%-10.72M
1,217.37%11.91M
-230.99%-10.69M
End cash Position
-30.39%215.24M
92.57%591.91M
-39.47%276.4M
-39.47%276.4M
-46.53%273.73M
-30.85%309.19M
-24.50%307.37M
-11.06%456.66M
-11.06%456.66M
8.87%511.94M
Free cash flow
-16.00%10.69M
-97.66%291K
-66.38%73.09M
-51.73%34.22M
-76.86%13.69M
-77.69%12.73M
-58.87%12.45M
-17.77%217.38M
69.60%70.88M
-21.64%59.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 42.87%40.4M-39.76%15.76M-47.08%139.96M-31.15%58.75M-60.81%26.77M-57.46%28.28M-41.02%26.16M-15.35%264.47M23.18%85.33M-17.48%68.31M
Net income from continuing operations -396.41%-12.4M-113.54%-3.28M-62.48%67.74M-62.54%19.83M-60.94%19.5M-90.66%4.18M-26.37%24.23M6.79%180.55M16.66%52.95M15.47%49.92M
Operating gains losses 1,646.91%1.25M152.17%12K110.42%777K110.11%781K121.65%100K-505.00%-81K-103.23%-23K81.15%-7.46M-2,133.42%-7.73M-121.26%-462K
Depreciation and amortization 19.31%36.78M-1.85%30.57M4.41%123.51M5.05%30.99M3.70%30.56M4.10%30.83M4.77%31.14M-1.28%118.3M-4.07%29.5M-2.17%29.47M
Deferred tax -712.33%-1.84M-246.24%-2.86M-159.21%-11.89M-146.48%-14.85M120.27%1.24M-105.68%-227K-44.89%1.95M-66.42%-4.59M-156.07%-6.02M28.96%-6.1M
Other non cash items 1.76%3.36M-74.48%2M299.58%21.24M831.71%6.11M138.73%3.98M268.56%3.3M733.23%7.85M-222.31%-10.64M-21.81%656K-578.15%-10.29M
Change In working capital 106.26%938K45.20%-23.35M-106.94%-81.57M-1.59%10.09M-969.18%-34.06M10.34%-14.99M-43.14%-42.61M-317.03%-39.42M140.62%10.26M-153.55%-3.19M
-Change in receivables -28.78%-6.72M67.58%16.83M113.55%4.59M95.45%-457K101.57%224K19.97%-5.22M422.24%10.04M-566.69%-33.91M1.35%-10.04M-314.59%-14.24M
-Change in inventory 181.75%1.74M25.18%-19.02M-105.24%-59.77M-250.84%-16.42M-130.01%-15.8M64.56%-2.13M-119.90%-25.42M-641.94%-29.12M-152.17%-4.68M-5.79%-6.87M
-Change in prepaid assets -68.87%-14.1M-23.66%-2.68M-69.21%2.65M248.73%24.35M-294.61%-11.19M-1,001.51%-8.35M57.11%-2.16M140.73%8.61M173.92%6.98M258.16%5.75M
-Change in payables and accrued expense 238.07%15.07M-285.43%-19.21M-216.64%-20.23M-89.46%1.91M-145.39%-6.24M-127.30%-10.92M48.90%-4.98M-47.24%17.34M1,944.11%18.15M108.98%13.75M
-Change in other current assets 522.16%9.18M105.64%339K-291.15%-8.54M102.03%239K-120.80%-590K-148.82%-2.18M-363.21%-6.01M-127.71%-2.18M-695.29%-11.76M54.77%2.84M
-Change in other current liabilities -158.60%-7.91M113.02%1.89M90.76%-410K-95.10%483K101.78%110K343.59%13.5M-463.00%-14.5M68.55%-4.44M163.06%9.85M-700.78%-6.17M
-Change in other working capital 1,147.28%3.67M-448.37%-1.5M-97.01%128K-100.74%-13K-133.31%-583K--294K--430K15,164.29%4.27M--1.75M--1.75M
Cash from discontinued investing activities
Operating cash flow 42.87%40.4M-39.76%15.76M-47.08%139.96M-31.15%58.75M-60.81%26.77M-57.46%28.28M-41.02%26.16M-15.35%264.47M23.18%85.33M-17.48%68.31M
Investing cash flow
Cash flow from continuing investing activities -1,972.28%-322.2M-293.79%-53.97M-60.77%-94.18M-4.39%-57.23M-151.99%-7.7M-245.66%-15.55M2.58%-13.7M63.71%-58.58M-99.45%-54.82M274.69%14.81M
Net PPE purchase and sale -91.07%-29.71M-12.85%-15.47M-114.32%-66.87M-641.01%-24.54M-42.85%-13.08M-65.28%-15.55M-46.96%-13.7M35.03%-31.2M87.93%-3.31M-25.70%-9.16M
Net intangibles purchase and sale ----------0--0-------------8,075.86%-4.74M--0--0
Net business purchase and sale ----------0--0--0--------75.72%-27.55M---51.51M----
Net investment purchase and sale ---10.5M---38.5M-656.39%-27.31M---32.69M--5.38M--0--06,359.21%4.91M--0--0
Cash from discontinued investing activities
Investing cash flow -1,972.28%-322.2M-293.79%-53.97M-60.77%-94.18M-4.39%-57.23M-151.99%-7.7M-245.66%-15.55M2.58%-13.7M63.71%-58.58M-99.45%-54.82M274.69%14.81M
Financing cash flow
Cash flow from continuing financing activities -776.72%-93.75M320.48%358.68M8.74%-229.93M92.95%-6.89M-549.82%-49.66M18.67%-10.69M-21.89%-162.68M-156.50%-251.95M-18,852.21%-97.7M-538.44%-7.64M
Net issuance payments of debt -171.32%-31.74M16,254.55%355.4M150.56%54.5M93.58%-6.5M1,252.31%74.9M-2,440.00%-11.7M-340.00%-2.2M-7.80%-107.8M-12,762.50%-101.3M-712.50%-6.5M
Net common stock issuance ---50M--0-120.00%-275M--0---125M--0-20.00%-150M---125M--0--0
Proceeds from stock option exercised by employees --0175.06%6.4M-21.01%4.32M-94.19%225K--655K214.73%1.11M87.73%2.33M-19.92%5.47M1,541.10%3.87M--0
Net other financing activities -11,442.31%-12M75.63%-3.12M44.18%-13.74M-126.10%-615K81.26%-214K99.26%-104K-39.17%-12.81M-387.49%-24.62M47.18%-272K-158.37%-1.14M
Cash from discontinued financing activities
Financing cash flow -776.72%-93.75M320.48%358.68M8.74%-229.93M92.95%-6.89M-549.82%-49.66M18.67%-10.69M-21.89%-162.68M-156.50%-251.95M-18,852.21%-97.7M-538.44%-7.64M
Net cash flow
Beginning cash position 92.57%591.91M-39.47%276.4M-11.06%456.66M-46.53%273.73M-30.85%309.19M-24.50%307.37M-11.06%456.66M9.21%513.45M8.87%511.94M12.52%447.15M
Current changes in cash -18,527.13%-375.55M313.32%320.47M-299.77%-184.15M92.01%-5.37M-140.52%-30.59M-95.83%2.04M-45.59%-150.23M-187.31%-46.06M-258.78%-67.19M-0.75%75.48M
Effect of exchange rate changes -428.17%-1.13M-629.67%-4.96M136.27%3.89M-32.50%8.04M54.41%-4.87M97.57%-213K129.58%937K-13.16%-10.72M1,217.37%11.91M-230.99%-10.69M
End cash Position -30.39%215.24M92.57%591.91M-39.47%276.4M-39.47%276.4M-46.53%273.73M-30.85%309.19M-24.50%307.37M-11.06%456.66M-11.06%456.66M8.87%511.94M
Free cash flow -16.00%10.69M-97.66%291K-66.38%73.09M-51.73%34.22M-76.86%13.69M-77.69%12.73M-58.87%12.45M-17.77%217.38M69.60%70.88M-21.64%59.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Brain-Computer Interface
Brain-Computer Interface
Intraday+0.94%